ClassID:

96736

C07K7/06 - page 14 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 5 to 11 amino acids

Recent Application in this class:
#3901
20130202634
2013-08-08

Dengue Virus (DV) Polypeptide Sequences, T Cell Epitopes and Methods and Uses Thereof

#3902
20130197190
2013-08-01

Method for producing surfactin and salt thereof

#3903
20130196902
2013-08-01

Beta-arrestin effectors and compositions and methods of use thereof

#3904
20130196896
2013-08-01

CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorders

#3905
20130195909
2013-08-01

Composite antigenic sequences and vaccines

#3906
20130195901
2013-08-01

SSX-2 PEPTIDE ANALOGS

#3907
20130193317
2013-08-01

Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry

#3908
20130190255
2013-07-25

Biologically active peptides and their new uses

#3909
20130190247
2013-07-25

PEPTIDE ANTAGONISTS OF ZONULIN AND METHODS FOR USE OF THE SAME

#3910
20130190241
2013-07-25

Biologically active peptides and their new uses

#3911
20130190240
2013-07-25

TUMOR GROWTH CONTROLLING METHOD TARGETING GALACTOSYLCERAMIDE EXPRESSION FACTOR-1

#3912
20130190233
2013-07-25

Peptides, derivatives and analogs thereof, and methods of using same

#3913
20130190228
2013-07-25

Antiviral peptides against influenza virus

#3914
20130189784
2013-07-25

ANTI-HEPARAN SULFATE PEPTIDES THAT BLOCK HERPES SIMPLEX VIRUS INFECTION IN VIVO

#3915
20130189291
2013-07-25

Peptide vaccines for cancers expressing tumor-associated antigens

#3916
20130184221
2013-07-18

Kinase inhibitors and uses thereof

#3917
20130184219
2013-07-18

Extract and peptides derived from Japonica Group and uses thereof

#3918
20130183378
2013-07-18

CD133 epitopes

#3919
20130183237
2013-07-18

Thrombin inhibitor

#3920
20130178835
2013-07-11

IDENTIFYING SYNTHETIC LIGANDS THAT BIND T-CELLS FROM PATIENTS HAVING AN AUTOIMMUNE DISEASE

#3921
20130177567
2013-07-11

NOVEL C3C EPITOPE, ANTIBODIES BINDING THERETO, AND USE THEREOF

#3922
20130172530
2013-07-04

JNK inhibitor molecules

#3923
20130172266
2013-07-04

Mitochondrial penetrating peptides as carriers for anticancer compounds

#3924
20130172242
2013-07-04

Growth hormone secretatogue receptor antagonists and uses thereof

#3925
20130172230
2013-07-04

Treating stroke and other diseases without inhibiting N-type calcium channels

#3926
20130171178
2013-07-04

Immunogenic Peptides of Xage-1

#3927
20130171074
2013-07-04

TARGETING COMPOUNDS

#3928
20130171069
2013-07-04

Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof

#3929
20130165629
2013-06-27

Bispecific T-cell activator antibody

#3930
20130165624
2013-06-27

Selective binding compounds

#3931
20130165388
2013-06-27

Method for treating wrinkles using a paralytic peptide from the shrew

#3932
20130164254
2013-06-27

Anticancer fusion protein comprising trail

#3933
20130164237
2013-06-27

Use of novel amino acid derivatives as agents for treating human perspiration, and compositions containing them

#3934
20130157949
2013-06-20

Novel Peptides for Wound Healing

#3935
20130157946
2013-06-20

Neurotrophic peptides

#3936
20130157943
2013-06-20

METHOD AND USE OF PEPTIDE ANTAGONISTS OF ZONOLIN TO PREVENT OR DELAY THE ONSET OF DIABETES

#3937
20130157936
2013-06-20

Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin

#3938
20130157931
2013-06-20

Mitochondrial penetrating peptides as carriers for antimicrobials

#3939
20130157338
2013-06-20

RHAMM binding peptides

#3940
20130156819
2013-06-20

ISOLATION OF MESENCHYMAL STEM CELLS

#3941
20130156723
2013-06-20

Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof

#3942
20130150301
2013-06-13

Therapeutic agents for regulating serum phosphorus

#3943
20130150300
2013-06-13

Specific binding sites in collagen for integrins and use thereof

#3944
20130150297
2013-06-13

Therapeutic agents for reducing parathyroid hormone levels

#3945
20130150283
2013-06-13

Short peptides useful for treatment of ischemia/reperfusion injury and other tissue damage conditions associated with nitric oxide and its reactive species

#3946
20130149323
2013-06-13

Mutant human and simian immunodeficiency virus ENV proteins with reduced immunosuppressive properties

#3947
20130149248
2013-06-13

αvβ6 peptide ligands and their uses

#3948
20130144037
2013-06-06

Lipid peptide and hydrogel

#3949
20130143823
2013-06-06

Compositions and methods of inhibiting apoptosis

#3950
20130143809
2013-06-06

Neurotrophic peptides

#3951
20130143791
2013-06-06

Peptides as active agents to stabilize biological barriers

#3952
20130143296
2013-06-06

Delivery system for cytotoxic drugs by bispecific antibody pretargeting

#3953
20130142764
2013-06-06

Methods and compositions for treating brain diseases

#3954
20130137637
2013-05-30

Peptides for promoting angiogenesis and use thereof

#3955
20130137631
2013-05-30

GIP and exendin hybrid polypeptides

#3956
20130137603
2013-05-30

Newly identified colon cancer marker and diagnostic kit using the same

#3957
20130136742
2013-05-30

PEPTIDE HAVING CELL MEMBRANE PENETRATING ACTIVITY

#3958
20130131311
2013-05-23

Aziridine mediated native chemical ligation

#3959
20130130976
2013-05-23

Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases

#3960
20130130970
2013-05-23

Lactadherin-derived peptides as antiviral agents

#3961
20130130969
2013-05-23

Antimicrobial peptide, branched forms thereof and their use in the treatment of bacteria infections

#3962
20130130268
2013-05-23

Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof

#3963
20130129972
2013-05-23

Porous thin films

#3964
20130129760
2013-05-23

Telomerase polypeptide vaccine for treating cancer

#3965
20130129759
2013-05-23

Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides

#3966
20130129736
2013-05-23

ASPP2 splicing variant

#3967
20130129621
2013-05-23

Integrin receptor antagonists and their methods of use

#3968
20130123465
2013-05-16

Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus

#3969
20130123464
2013-05-16

CEACAM based antibacterial agents

#3970
20130123460
2013-05-16

PEPTIDE FOR IMPROVING BIOSTABILITY OF BIOACTIVE SUBSTANCE, AND BIOACTIVE SUBSTANCE HAVING IMPROVED BIOSTABILITY

#3971
20130123202
2013-05-16

Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles

#3972
20130123192
2013-05-16

Compositions and methods for inhibiting matrix metalloproteinase (MMP)-mediated cell migration

#3973
20130123187
2013-05-16

PEPTIDES FOR THE REGULATION OF NEUROTRANSMITTER SEQUESTRATION AND RELEASE

#3974
20130123186
2013-05-16

NEUROPROTECTION USING NAP-LIKE AND SAL-LIKE PEPTIDE MIMETICS

#3975
20130123170
2013-05-16

Growth hormone releasing peptides

#3976
20130123140
2013-05-16

Identification of compounds modifying a cellular response

#3977
20130122031
2013-05-16

HMGB1-derived peptides enhance immune response to antigens

#3978
20130122030
2013-05-16

S. EPIDERMIDIS ANTIGENS

#3979
20130122029
2013-05-16

CANCER VACCINE

#3980
20130122024
2013-05-16

NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF

#3981
20130116406
2013-05-09

BORRELIA ANTIGENS

#3982
20130116184
2013-05-09

RFamide-Related Peptides and Methods Thereof

#3983
20130116168
2013-05-09

Pea protein peptides with anti activity

#3984
20130116138
2013-05-09

Peptide domains that bind small molecules of industrial significance

#3985
20130115279
2013-05-09

CD133 epitopes

#3986
20130115256
2013-05-09

METHODS FOR TREATING OR PREVENTING VASCULAR GRAFT FAILURE

#3987
20130115226
2013-05-09

Methods and uses of TIE2 binding and/or activating agents

#3988
20130109626
2013-05-02

Peptide and use thereof

#3989
20130109619
2013-05-02

Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling

#3990
20130109618
2013-05-02

RNA virus-derived peptides with modified side chains

#3991
20130109580
2013-05-02

High-Affinity Peptide Probes for Tumor Biomarker, GRP-78, and Screening Method Thereof

#3992
20130109578
2013-05-02

Differentiation of isobaric amino acids and other species

#3993
20130108664
2013-05-02

CDCA5 PEPTIDES AND VACCINES INCLUDING THE SAME

#3994
20130108656
2013-05-02

Peptide for reducing the phosphate requirement and excretion from farm animals

#3995
20130108614
2013-05-02

Wound healing peptides and methods of use thereof

#3996
20130108575
2013-05-02

Antibacterial and antifungal peptides

#3997
20130108548
2013-05-02

Peptide derivatives, preparation and uses thereof

#3998
20130102758
2013-04-25

Ezrin assay method for the in vitro diagnosis of colorectal cancer

#3999
20130102757
2013-04-25

Methods for selective targeting

#4000
20130102633
2013-04-25

Transglutaminase inhibitors and methods of use thereof

#4001
20130102547
2013-04-25

Use of tight junction antagonists to treat inflammatory bowel disease

#4002
20130102539
2013-04-25

Peptoids and methods for treating alzheimer's disease

#4003
20130102522
2013-04-25

INHIBITORS OF PROTEIN KINASES AND USES THEREOF

#4004
20130102498
2013-04-25

Methods for enhancing neprilysin activity and degrading amyloid-beta peptides and oligomers in a subject with Alzheimer's disease

#4005
20130101662
2013-04-25

Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions

#4006
20130101624
2013-04-25

LINEAR IGE PEPTIDE EPITOPES OF HAZELNUT ALLERGEN COR A 1 AND CELERY ANTIGEN API 1

#4007
20130096072
2013-04-18

Zymogen activators

#4008
20130096070
2013-04-18

PEPTIDE TARGETING OF INNER EAR CELLS

#4009
20130095128
2013-04-18

ECT2 peptides and vaccines including the same

#4010
20130095123
2013-04-18

Binder-drug conjugates (ADCs) and use thereof

#4011
20130095122
2013-04-18

Peptides or Antibodies Which Bind to Melanoma Inhibitory Activity (MIA) Protein

#4012
20130095092
2013-04-18

Recombinant human NaGlu protein and uses thereof

#4013
20130090293
2013-04-11

Protein scaffolds for targeted delivery of toxic iron to cancer cells

#4014
20130089525
2013-04-11

Antimicrobial compositions and methods of use thereof

#4015
20130089498
2013-04-11

COMPOSITIONS AND METHODS RELATED TO PROFILING A PLURALITY OF CELLS BASED ON PEPTIDE BINDING

#4016
20130085261
2013-04-04

Binding partners of antibodies specific for dendritic cell antigens

#4017
20130085188
2013-04-04

PEPTIDE NETWORKS

#4018
20130085108
2013-04-04

Peptides for promoting angiogenesis and an use thereof

#4019
20130084618
2013-04-04

PHENOLIC BINDING PEPTIDES

#4020
20130084303
2013-04-04

Peptides shared among lethal cancers and therapeutic compositions comprising said peptides

#4021
20130084283
2013-04-04

Oligomer-specific amyloid beta epitope and antibodies

#4022
20130079493
2013-03-28

Method for prepairing peptide inhibitors of a lipid-activated enzyme and peptides produced by same

#4023
20130079292
2013-03-28

Cyclic peptides binding CXCR4 receptor and relative medical and diagnostic uses

#4024
20130078227
2013-03-28

Embedded chimeric peptide nucleic acids and uses thereof

#4025
20130072581
2013-03-21

Secreted protein acidic and rich in cysteine (SPARC) protein SRM assay

#4026
20130072433
2013-03-21

Inhibitors of beta integrin-G protein alpha subunit binding interactions

#4027
20130072431
2013-03-21

Cardiovascular therapeutics

#4028
20130071411
2013-03-21

IAP BIR domain binding compounds

#4029
20130066055
2013-03-14

NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF

#4030
20130065840
2013-03-14

Method and peptide for regulating cellular activity

#4031
20130065837
2013-03-14

Integrin interaction inhibitors for the treatment of cancer

#4032
20130065829
2013-03-14

PEPTIDES AND SUPPORTED PEPTIDES FOR TREATING SKIN DISEASES

#4033
20130065325
2013-03-14

Zwitterionic reagents

#4034
20130065267
2013-03-14

CONJUGATES AND METHODS FOR MEASURING CHAPERONE-MEDIATED AUTOPHAGY

#4035
20130064895
2013-03-14

Amphiphilic peptides and peptide particles

#4036
20130064843
2013-03-14

Identification of conserved peptide blocks in homologous polypeptides

#4037
20130064841
2013-03-14

Immunogenic compositions against human progastrin peptides

#4038
20130064840
2013-03-14

HJURP peptides and vaccines including the same

#4039
20130064791
2013-03-14

Interferon analogs

#4040
20130059793
2013-03-07

EGF RECEPTOR MIMICKING PEPTIDES

#4041
20130058993
2013-03-07

METHODS AND COMPOSITIONS FOR ENHANCING WOUND HEALING USING CAR PEPTIDES

#4042
20130053426
2013-02-28

Composition For Delivery Of Genetic Material

#4043
20130053327
2013-02-28

Polypeptide expressed in the stratum corneum and thereof

#4044
20130053324
2013-02-28

Self-assembling peptides and their use in the formation of hydrogels

#4045
20130053321
2013-02-28

Inhibitors of mitochondrial fission and methods of use thereof

#4046
20130053305
2013-02-28

PEPTIDE COMPOUNDS THAT CAN BE USED AS ANTIBACTERIAL AGENTS

#4047
20130046077
2013-02-21

DOLASTATIN 15 DERIVATIVES

#4048
20130045191
2013-02-21

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#4049
20130040857
2013-02-14

Mass spectrometric assays for peptides

#4050
20130039935
2013-02-14

Induction of tumor immunity by variants of folate binding protein

#4051
20130035286
2013-02-07

Pharmaceutical Composition Comprising Cyclic Somatostatin Analogues

#4052
20130034519
2013-02-07

Peptidomimetic sulfamide compounds and antiviral uses thereof

#4053
20130028923
2013-01-31

KDR peptides and vaccines comprising the same

#4054
20130023485
2013-01-24

PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMATIC LUPUS ERYTHEMATOSUS

#4055
20130023460
2013-01-24

Amphiphilic linear peptide/peptoid and hydrogel comprising the same

#4056
20130022993
2013-01-24

Screening method for an insulin resistance improving agent or a therapeutic agent for diabetes

#4057
20130022572
2013-01-24

Peptidomimetic sulfamide compounds and antiviral uses thereof

#4058
20130019325
2013-01-17

Light-sensitive ion-passing molecules

#4059
20130018003
2013-01-17

Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles

#4060
20130018002
2013-01-17

Compositions and methods for treating cancer by inhibiting the secretion of microparticles

#4061
20130017600
2013-01-17

ISOLATION AND/OR PRESERVATION OF DENDRITIC CELLS FOR PROSTATE CANCER IMMUNOTHERAPY

#4062
20130017213
2013-01-17

Peptide analogues

#4063
20130012457
2013-01-10

Beta sheet tapes ribbons in tissue engineering

#4064
20130012430
2013-01-10

INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE

#4065
20130004941
2013-01-03

Proteinase K inhibitors, methods and compositions therefor

#4066
20130004456
2013-01-03

Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers

#4067
20130004431
2013-01-03

Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof

#4068
20130004415
2013-01-03

Joint-homing peptides and uses thereof

#4069
20120329986
2012-12-27

Heteropeptides useful for reducing nonspecific adsorption

#4070
20120329730
2012-12-27

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

#4071
20120329728
2012-12-27

Compositions and methods for modulating γ-c-cytokine activity

#4072
20120329716
2012-12-27

Yellow pea seed protein-derived peptides

#4073
20120328636
2012-12-27

KDR peptides and vaccines comprising the same

#4074
20120328512
2012-12-27

Fibrin-binding peptides and conjugates thereof

#4075
20120322748
2012-12-20

Synthetic peptides that enhance tight junction permeability

#4076
20120322740
2012-12-20

Mu opioid receptor agonist analogs of the endomorphins

#4077
20120321649
2012-12-20

Peptide vaccines for cancers expressing tumor-associated antigens

#4078
20120316318
2012-12-13

Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor

#4079
20120316101
2012-12-13

Peptides for targeting apoptotic cells and uses thereof

#4080
20120316100
2012-12-13

Therapeutic use of peptide inhibitors of NADPH oxidase; aerosolization as a delivery mechanism

#4081
20120315701
2012-12-13

Peptide inhibiting differentiation of hematopoietic stem cells or hematopoietic precursor cells and use of same

#4082
20120315220
2012-12-13

Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use

#4083
20120309938
2012-12-06

Hemiasterlin derivatives and uses thereof in the treatment of cancer

#4084
20120309937
2012-12-06

Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability

#4085
20120309692
2012-12-06

Activation of peptide prodrugs by hK2

#4086
20120308591
2012-12-06

TMEM22 peptides and vaccines including the same

#4087
20120302511
2012-11-29

Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer

#4088
20120301518
2012-11-29

Biocompatible and biodegradable elastomeric polymers

#4089
20120295957
2012-11-22

Prevention of tissue ischemia and related compositions

#4090
20120295956
2012-11-22

Prevention of tissue ischemia and related methods

#4091
20120295838
2012-11-22

Selective poly-substituted glycine antibiotics and related compositions

#4092
20120295837
2012-11-22

NOVEL ANTIMICROBIAL AGENTS

#4093
20120294801
2012-11-22

Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses

#4094
20120289458
2012-11-15

Treatment of influenza virus infection

#4095
20120289454
2012-11-15

Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof

#4096
20120288514
2012-11-15

Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides

#4097
20120288447
2012-11-15

Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof

#4098
20120283415
2012-11-08

Multivalent Antibodies

#4099
20120283410
2012-11-08

ATTACHMENT OF BIOLOGICAL TARGETING GROUPS USING METAL FREE CLICK CHEMISTRY

#4100
20120283194
2012-11-08

Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers

#4101
20120283168
2012-11-08

Template-fixed peptidomimetics with CCR10 antagonistic activity

#4102
20120282286
2012-11-08

Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides

#4103
20120282219
2012-11-08

Peptidomimetic protease inhibitors

#4104
20120277406
2012-11-01

Processes for the manufacture of macrocyclic depsipeptides and new intermediates

#4105
20120276039
2012-11-01

Aptamer-modified polymeric materials for the binding of factors in a wound environment

#4106
20120270812
2012-10-25

COMPOSITIONS, METHODS, AND KITS FOR DETERMINING AN ALKYL TRANSFERASE

#4107
20120270790
2012-10-25

Compositions and methods for the treatment of myocardial ischemia/reperfusion injury with Annexin A1 short peptide

#4108
20120270768
2012-10-25

Tumor activated prodrugs

#4109
20120270767
2012-10-25

Tumor activated prodrugs

#4110
20120270741
2012-10-25

Biomarker discovery in complex biological fluid using bead or particle based libraries and diagnostic kits and therapeutics

#4111
20120269843
2012-10-25

S. epidermidis antigens

#4112
20120269799
2012-10-25

DIAGNOSTIC AND TREATMENT METHODS USING A LIGAND LIBRARY

#4113
20120264912
2012-10-18

Self-assembling peptide amphiphiles and related methods for growth factor delivery

#4114
20120264681
2012-10-18

BUFFERED OPHTHALMIC COMPOSITIONS AND METHODS OF USE THEREOF

#4115
20120263665
2012-10-18

Peptides useful for skin lightening

#4116
20120263645
2012-10-18

RADIOLABELED COMPOUND DIRECTABLE IN VIVO TO TARGET TISSUE AND USE THEREOF

#4117
20120258865
2012-10-11

Mirac proteins

#4118
20120253011
2012-10-04

Native chemical ligation at serine and threonine sites

#4119
20120253009
2012-10-04

THROMBOPOIETIC COMPOUNDS

#4120
20120252734
2012-10-04

Inhibitors of antigen presentation by MHC class II molecules

#4121
20120244136
2012-09-27

Cardiac-specific protein targeting domain

#4122
20120238723
2012-09-20

Production method of 11-sugar sialylglycopeptide

#4123
20120238505
2012-09-20

Medicaments

#4124
20120238490
2012-09-20

Methods and compositions for the treatment of metabolic disorders

#4125
20120237569
2012-09-20

EMULSIFIED COMPOSITION FOR DILUTION AND CANCER VACCINE COMPOSITION

#4126
20120237504
2012-09-20

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION AND FIBROSIS

#4127
20120231026
2012-09-13

Methods and compositions for tumor vaccination and therapy

#4128
20120230994
2012-09-13

Bladder cancer specific ligand peptides

#4129
20120230947
2012-09-13

BIOLOGICALLY ACTIVE PROTEINS HAVING INCREASED IN VIVO AND/OR IN VITRO STABILITY

#4130
20120225831
2012-09-06

Melanocortin-1 receptor-specific linear peptides

#4131
20120225811
2012-09-06

Insulin analogues

#4132
20120220536
2012-08-30

Use of endostatin peptides for the treatment of fibrosis

#4133
20120220519
2012-08-30

Peptide aptamers that bind to the rep proteins of ssDNA viruses

#4134
20120220013
2012-08-30

Covalent tethering of functional groups to proteins and substrates therefor

#4135
20120220011
2012-08-30

UNSTRUCTURED RECOMBINANT POLYMERS AND USES THEREOF

#4136
20120219505
2012-08-30

Peptide reagents and methods for detection of colon dysplasia

#4137
20120219504
2012-08-30

Complex of a protein comprising zinc oxide-binding peptides and zinc oxide nanoparticles, and use thereof

#4138
20120219499
2012-08-30

Compositions and methods for detecting plectin-1 as a biomarker for cancer

#4139
20120219498
2012-08-30

Compositions and methods for inducing angiogenesis

#4140
20120214709
2012-08-23

ISOLATING BIOLOGICAL MODULATORS FROM BIODIVERSE GENE FRAGMENT LIBRARIES

#4141
20120214235
2012-08-23

Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory

#4142
20120213809
2012-08-23

Vault complexes for cytokine delivery

#4143
20120208774
2012-08-16

METHOD FOR INHIBITING "MELANOMA INHIBITORY ACTIVITY" MIA

#4144
20120208770
2012-08-16

Carcinoma homing peptide (CHP), its analogs, and methods of using

#4145
20120208768
2012-08-16

SPECIFIC BINDING SITES IN COLLAGEN FOR INTEGRINS AND USE THEREOF

#4146
20120208760
2012-08-16

Thrombopoietic compounds

#4147
20120208752
2012-08-16

Cell proliferation-promoting peptide and use thereof

#4148
20120207756
2012-08-16

Modified antibody compositions, methods of making and using thereof

#4149
20120207675
2012-08-16

Method of colorectal cancer detection by using radiolabeled anti-GRP78 peptide

#4150
20120203102
2012-08-09

Azulene and azaazulene systems for imaging, monitoring and therapy

#4151
20120202970
2012-08-09

Fragment ligated inhibitors selective for the polo box domain of PLK1

#4152
20120202969
2012-08-09

Method for insulin resistance improving and a method for prevention or treatment of diabetes

#4153
20120202750
2012-08-09

Inhibitors of IAP

#4154
20120201840
2012-08-09

EphA2 T cell epitopes and uses therefor

#4155
20120201753
2012-08-09

Methods and compositions related to targeting wounds, regenerating tissue, and tumors

#4156
20120195918
2012-08-02

Method of treating cancer with an HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same

#4157
20120190819
2012-07-26

Scaffold polypeptides for heterologous peptide display

#4158
20120190818
2012-07-26

Triazole macrocycle systems

#4159
20120190626
2012-07-26

Amyloid β fibrillogenesis-inhibiting peptide

#4160
20120190625
2012-07-26

Peptide and use thereof

#4161
20120190622
2012-07-26

Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction

#4162
20120190614
2012-07-26

HCV protease inhibitors and uses thereof

#4163
20120189647
2012-07-26

Mutated env sequence involved in the modulation of the immunosuppressive effect of viral proteins

#4164
20120184710
2012-07-19

antigens

#4165
20120183598
2012-07-19

HLA-A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND COMPOSITIONS

#4166
20120178901
2012-07-12

Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof

#4167
20120178900
2012-07-12

CHROMATOGRAPHIC PROCESSES AND PURIFIED COMPOUNDS THEREOF

#4168
20120178688
2012-07-12

Therapeutic agents for reducing parathyroid hormone levels

#4169
20120178649
2012-07-12

METHODS OF CONSTRUCTING AND SCREENING DIVERSE EXPRESSION LIBRARIES

#4170
20120172318
2012-07-05

Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin Freceptor

#4171
20120172312
2012-07-05

MUC-1 cytoplasmic domain peptides as inhibitors of cancer

#4172
20120172310
2012-07-05

Treatment of cancers with A-8R peptide

#4173
20120172309
2012-07-05

Transglutaminase-activating peptide and cosmetic or pharmaceutical composition containing same

#4174
20120172285
2012-07-05

Methods and compositions for specific modulation of MCL-1

#4175
20120171234
2012-07-05

Biologically active peptides and their new uses

#4176
20120171233
2012-07-05

Peptide inhibitors for mediating stress responses

#4177
20120165250
2012-06-28

Active cores of peptide triazole HIV-1 entry inhibitors

#4178
20120165249
2012-06-28

Stabilized therapeutic small helical antiviral peptides

#4179
20120165230
2012-06-28

BIOLOGICALLY PRODUCED CYCLIC AFFINITY TAGS

#4180
20120164685
2012-06-28

Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

#4181
20120164127
2012-06-28

Mirac proteins

#4182
20120157659
2012-06-21

AFFINITY PEPTIDES AND METHOD FOR PURIFICATION OF RECOMBINANT PROTEINS

#4183
20120157389
2012-06-21

Peptides for treating cancer

#4184
20120157372
2012-06-21

Human milk peptides

#4185
20120156279
2012-06-21

High penetration prodrug compositions of peptides and peptide-related compounds

#4186
20120156276
2012-06-21

Connective tissue stimulating peptides

#4187
20120156215
2012-06-21

Phage-GnRH Constructs, Their Mimics, Antigenic Compositions, and Sequences for Immunocontraception of Animals and Other Applications

#4188
20120149634
2012-06-14

Compounds and methods for treating bone disorders and controlling weight

#4189
20120149061
2012-06-14

Modified antibody compositions, methods of making and using thereof

#4190
20120149053
2012-06-14

CARRIER PEPTIDE FRAGMENT AND USE THEREOF

#4191
20120148674
2012-06-14

Self-assembling hydrogels based on dicephalic peptide amphiphiles

#4192
20120142894
2012-06-07

Identification, optimization and use of shared HLA-B*0702 epitopes for immunotherapy

#4193
20120142062
2012-06-07

Engineered cleavage half-domains

#4194
20120141517
2012-06-07

Immunotherapy against several tumors including neuronal and brain tumors

#4195
20120141516
2012-06-07

Compositions and methods for inducing an immune response

#4196
20120141499
2012-06-07

Specific binding agents of human angiopoietin-2

#4197
20120134931
2012-05-31

Peptides whose uptake in cells is controllable

#4198
20120134922
2012-05-31

Peptides whose uptake in cells is controllable

#4199
20120130049
2012-05-24

Albumin-amyloid peptide conjugates and uses thereof

#4200
20120129792
2012-05-24

AGENT FOR ELIMINATING MULTIDRUG RESISTANCE